0001950047-24-000956.txt : 20240215 0001950047-24-000956.hdr.sgml : 20240215 20240215160639 ACCESSION NUMBER: 0001950047-24-000956 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 24643824 BUSINESS ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Valantine Hannah CENTRAL INDEX KEY: 0001855608 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 144 1 primary_doc.xml 144 0001855608 XXXXXXXX LIVE 0001743881 BRIDGEBIO PHARMA, INC. 001-38959 3160 Porter Drive Suite 250 Palo Alto CA 94304 (650) 391-9740 HANNAH A VALANTINE Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

2915 110041.25 173967052 02/15/2024 NASDAQ Common 02/15/2024 Stock option exercise Issuer N 2915 02/15/2024 Cash N HANNAH A VALANTINE

3160 Porter Drive Suite 250 Palo Alto CA 94304

Common 01/16/2024 2915 110682.55 HANNAH A VALANTINE

3160 Porter Drive Suite 250 Palo Alto CA 94304

Common 12/15/2023 2915 105289.80 02/15/2024 08/16/2023 /s/ Hannah A Valantine